02 August 2024
Indian pharmaceutical companies are keen to localize their drug production in Russia, seeking joint ventures in the sector. This trend of establishing manufacturing bases in partner countries is seen as natural by both Indian and Russian firms, according to Mir Faruk, Vice President of the Indian Business Council and head of Ipca Laboratories’ Russian office.
“We need to move in this direction and localize production [of Indian drugs] in Russia. Especially when it comes to pharmaceutical substances, where we are very strong,” he emphasized. He noted that many Indian pharmaceutical manufacturers have already opened their sites in Russia, while others are still considering this possibility. There are also Russian entrepreneurs who want and can work in the Indian pharmaceutical market, Faruk noted.
He also said that there is potential for this. “And I think that the time has come for this, since our countries now have excellent relations at all levels. I think that the interaction of our countries in the pharmaceutical industry will continue to develop,” the agency’s interlocutor said. In 2023, India was the largest supplier of drugs to Russia (300 million packages).
PrintMerry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
New guidance to aid cost-effectiveness analysis of new drugs
20 January 2025
The Ministry of Health may expand its patent use powers
20 January 2025
Gene therapy gel for epidermolysis bullosa is now used in Russia
20 January 2025
In 2024, salaries of Russian medical workers in the ambulance service increased by 12-14%
17 January 2025